Dashboard
Manage Tickers

VTYX Ventyx Biosciences, Inc.

Nasdaq ventyxbio.com


$ 8.38 $ 0.11 (1.31 %)    

Friday, 31-Oct-2025 18:42:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 8.53
$ 8.42
$ 8.35 x 7
$ 8.90 x 122
$ 8.10 - $ 9.50
$ 0.78 - $ 9.50
5,419,960
na
608.26M
$ 0.90
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-27-2025 12-31-2024 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 02-27-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-23-2023 12-31-2022 10-K
12 11-04-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-23-2022 12-31-2021 10-K
16 11-18-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

oppenheimer-maintains-outperform-on-ventyx-biosciences-raises-price-target-to-14
Oppenheimer Maintains Outperform on Ventyx...
10/27/2025 12:54:30

Oppenheimer analyst Jeff Jones maintains Ventyx Biosciences (NASDAQ:VTYX) with a Outperform and raises the price target from...

crude-oil-surges-5-american-airlines-shares-jump-after-q3-results
Crude Oil Surges 5%; American Airlines Sha...
10/23/2025 19:23:59

ventyx-stock-is-rallying-thursday-whats-driving-the-surge
Ventyx Stock Is Rallying Thursday: What's ...
10/23/2025 17:40:54

Ventyx Biosciences Inc (NASDAQ:VTYX) shares are surging Thursday after the company announced positive Phase 2 study results for...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/23/2025 17:07:13

dow-gains-50-points-tesla-shares-slide-after-q3-earnings
Dow Gains 50 Points; Tesla Shares Slide Af...
10/23/2025 13:56:49

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/23/2025 12:07:49

why-lendingclub-shares-are-trading-higher-by-around-13-here-are-20-stocks-moving-premarket
Why LendingClub Shares Are Trading Higher ...
10/23/2025 08:55:01

why-ventyx-vtyx-shares-soared-865-after-hours
Why Ventyx (VTYX) Shares Soared 86.5% Afte...
10/23/2025 04:34:45

Ventyx shares jumped 86.5% in after-hours trading after positive Phase 2 trial results.

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/22/2025 21:06:21

ventyx-biosciences-announces-positive-results-from-phase-2-trial-of-vtx3232-for-obesity-cardiovascular-risk-factors-vtx3232-monotherapy-achieved-80-reduction-in-hscrp-vtx3232-monotherapy-reduced-il-6-levels
Ventyx Biosciences Announces Positive Resu...
10/22/2025 20:05:11

Ventyx Biosciences, Inc. (Nasdaq: VTYX) ("Ventyx", "Company"), today announced positive results from its Phase ...

clear-street-initiates-coverage-on-ventyx-biosciences-with-buy-rating-announces-price-target-of-11
Clear Street Initiates Coverage On Ventyx ...
10/01/2025 12:57:46

Clear Street analyst Kaveri Pohlman initiates coverage on Ventyx Biosciences (NASDAQ:VTYX) with a Buy rating and announces P...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
09/22/2025 17:06:11

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
09/05/2025 21:06:11

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
08/11/2025 21:06:28

ventyx-biosciences-q2-eps-038-beats-045-estimate
Ventyx Biosciences Q2 EPS $(0.38) Beats $(...
08/07/2025 20:50:29

Ventyx Biosciences (NASDAQ:VTYX) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(...

trading-halt-halt-status-updated-at-72500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 7:25:...
06/17/2025 11:25:04

ventyx-biosciences-announces-topline-results-from-phase-2a-study-of-vtx3232-in-early-stage-parkinsons-disease-says-vtx3232-resulted-in-reductions-in-nlrp3-related-biomarkers-in-csf-and-plasma
Ventyx Biosciences Announces Topline Resul...
06/17/2025 11:08:04

trading-halt-halted-at-65500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 6:55:00 a.m. ET - ...
06/17/2025 10:55:05

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
05/22/2025 17:06:46

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
05/22/2025 12:10:00

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION